Cargando…
Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
Pneumococcal conjugate vaccine (PCV) has reduced the burden of pneumococcal disease by the near elimination of vaccine serotypes from countries giving a booster dose at >9 months of life. Herd protection, induced by interruption of pneumococcal vaccine type transmission has protected children too...
Autores principales: | Rodgers, Gail L, Whitney, Cynthia G, Klugman, Keith P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482025/ https://www.ncbi.nlm.nih.gov/pubmed/34590137 http://dx.doi.org/10.1093/infdis/jiaa535 |
Ejemplares similares
-
Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020) -
Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015) -
Population versus individual protection by pneumococcal conjugate
vaccination
por: Klugman, Keith P, et al.
Publicado: (2019) -
Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
por: Whitney, Cynthia G., et al.
Publicado: (2014) -
Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization
por: Loo, Jennifer D., et al.
Publicado: (2014)